Anorexigenic peptide (leptin, obestatin, nesfatin-1) levels and their impact on assisted reproductive technology treatment outcomes in patients with polycystic ovary syndrome

VARLI, BULUT; ŞÜKÜR, YAVUZ; ÖZMEN, BATUHAN; Ergüder, BERRİN; SÖNMEZER, MURAT; BERKER, BÜLENT; Atabekoğlu, Cem; Aytaç, Ruşen

doi:10.5653/cerm.2021.04420

Anorexigenic peptide (leptin, obestatin, nesfatin-1) levels and their impact on assisted reproductive technology treatment outcomes in patients with polycystic ovary syndrome

VARLI B., ŞÜKÜR Y. E., ÖZMEN B., Ergüder B. İ., SÖNMEZER M., BERKER B., ...Daha Fazla

CLINICAL AND EXPERIMENTAL REPRODUCTIVE MEDICINE, cilt.48, sa.4, ss.368-373, 2021 (ESCI, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 48 Sayı: 4
Basım Tarihi: 2021
Doi Numarası: 10.5653/cerm.2021.04420
Dergi Adı: CLINICAL AND EXPERIMENTAL REPRODUCTIVE MEDICINE
Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier
Sayfa Sayıları: ss.368-373
Anahtar Kelimeler: Assisted reproductive technique, Leptin, Nesfatin, Obestatin, Polycystic ovary syndrome, ENDOTHELIAL GROWTH-FACTOR, FOLLICULAR-FLUID LEVELS, GHRELIN, WOMEN, FERTILIZATION, INSULIN, SERUM, GENE
Ankara Üniversitesi Adresli: Evet

Özet

Objective: In this study we aimed to assess anorexigenic peptide levels in patients with or without polycystic ovary syndrome (PCOS) and their effects on assisted reproductive treatment (ART) outcomes.